MSB 5.24% $1.11 mesoblast limited

banter and General Discussion, page-9397

  1. 304 Posts.
    lightbulb Created with Sketch. 340
    Some interesting insights on off-label use - stroll to the bottom for a summary if you are interested but haven’t got time; otherwise, look for the framework that is useful for thinking about this from a physician’s point of view, which is how the regulator would like to “adopt” when thinking of the topic:

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998554/

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3538391/

    https://www.fda.gov/drugs/fdas-labeling-resources-human-prescription-drugs/prescribing-information-resources
    (labeling resources page which includes a video to guide industry participants whose job it is to compile prescription information)

    https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label

    Last edited by irenekwshiu: 07/04/24
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.